192 related articles for article (PubMed ID: 15808955)
21. Drug insight: role of the androgen receptor in the development and progression of prostate cancer.
Taplin ME
Nat Clin Pract Oncol; 2007 Apr; 4(4):236-44. PubMed ID: 17392714
[TBL] [Abstract][Full Text] [Related]
22. Molecular regulation of androgen action in prostate cancer.
Dehm SM; Tindall DJ
J Cell Biochem; 2006 Oct; 99(2):333-44. PubMed ID: 16518832
[TBL] [Abstract][Full Text] [Related]
23. Androgen receptor action in hormone-dependent and recurrent prostate cancer.
Agoulnik IU; Weigel NL
J Cell Biochem; 2006 Oct; 99(2):362-72. PubMed ID: 16619264
[TBL] [Abstract][Full Text] [Related]
24. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
[TBL] [Abstract][Full Text] [Related]
25. Androgen receptor amplification is associated with increased cell proliferation in prostate cancer.
Haapala K; Kuukasjärvi T; Hyytinen E; Rantala I; Helin HJ; Koivisto PA
Hum Pathol; 2007 Mar; 38(3):474-8. PubMed ID: 17217995
[TBL] [Abstract][Full Text] [Related]
26. A coregulatory role for the mediator complex in prostate cancer cell proliferation and gene expression.
Vijayvargia R; May MS; Fondell JD
Cancer Res; 2007 May; 67(9):4034-41. PubMed ID: 17483314
[TBL] [Abstract][Full Text] [Related]
27. Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth.
Takayama K; Tsutsumi S; Suzuki T; Horie-Inoue K; Ikeda K; Kaneshiro K; Fujimura T; Kumagai J; Urano T; Sakaki Y; Shirahige K; Sasano H; Takahashi S; Kitamura T; Ouchi Y; Aburatani H; Inoue S
Cancer Res; 2009 Jan; 69(1):137-42. PubMed ID: 19117996
[TBL] [Abstract][Full Text] [Related]
28. Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survival.
Sterbis JR; Gao C; Furusato B; Chen Y; Shaheduzzaman S; Ravindranath L; Osborn DJ; Rosner IL; Dobi A; McLeod DG; Sesterhenn IA; Srivastava S; Cullen J; Petrovics G
Clin Cancer Res; 2008 Feb; 14(3):758-63. PubMed ID: 18245536
[TBL] [Abstract][Full Text] [Related]
29. Molecular targets in cerebral ischemia for developing novel therapeutics.
Mehta SL; Manhas N; Raghubir R
Brain Res Rev; 2007 Apr; 54(1):34-66. PubMed ID: 17222914
[TBL] [Abstract][Full Text] [Related]
30. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
Man YG; Gardner WA
Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
[TBL] [Abstract][Full Text] [Related]
31. Cell cycle regulator cdk2ap1 inhibits prostate cancer cell growth and modifies androgen-responsive pathway function.
Zolochevska O; Figueiredo ML
Prostate; 2009 Oct; 69(14):1586-97. PubMed ID: 19585490
[TBL] [Abstract][Full Text] [Related]
32. Molecular markers and their prognostic impact in patients with advanced prostate cancer undergoing intermittent androgen suppression.
Augustin H; Freibauer C; Bayer L; Lunglmayr G; Tschurlovich F; Kuber W; Pummer K
Prostate Cancer Prostatic Dis; 2006; 9(3):279-83. PubMed ID: 16702984
[TBL] [Abstract][Full Text] [Related]
33. Targeting angiogenesis in lung cancer.
Sandler AB
Semin Oncol; 2005 Dec; 32(6 Suppl 10):S16-22. PubMed ID: 16459175
[TBL] [Abstract][Full Text] [Related]
34. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW
Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539
[TBL] [Abstract][Full Text] [Related]
35. cDNA microarray analysis identifies genes induced in common by peptide growth factors and androgen in human prostate epithelial cells.
York TP; Plymate SR; Nelson PS; Eaves LJ; Webb HD; Ware JL
Mol Carcinog; 2005 Dec; 44(4):242-51. PubMed ID: 16240454
[TBL] [Abstract][Full Text] [Related]
36. Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells.
Hsieh CL; Cai C; Giwa A; Bivins A; Chen SY; Sabry D; Govardhan K; Shemshedini L
J Mol Endocrinol; 2008 Jul; 41(1):13-23. PubMed ID: 18469090
[TBL] [Abstract][Full Text] [Related]
37. [Molecular biology and prostate cancer: evolution or revolution?].
Molinié V; Beuzeboc P; Mahjoub WK;
Ann Pathol; 2008 Oct; 28(5):354-62. PubMed ID: 19068390
[TBL] [Abstract][Full Text] [Related]
38. Prognostic relevance of molecular markers of oral cancer--a review.
Schliephake H
Int J Oral Maxillofac Surg; 2003 Jun; 32(3):233-45. PubMed ID: 12767868
[TBL] [Abstract][Full Text] [Related]
39. Prostate cancer prevention: investigational approaches and opportunities.
Karp JE; Chiarodo A; Brawley O; Kelloff GJ
Cancer Res; 1996 Dec; 56(24):5547-56. PubMed ID: 8971151
[No Abstract] [Full Text] [Related]
40. Prostate cancer biomarkers: a current perspective.
Kumar-Sinha C; Rhodes DR; Yu J; Chinnaiyan AM
Expert Rev Mol Diagn; 2003 Jul; 3(4):459-70. PubMed ID: 12877385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]